Search

everythinglearnresearchcommunity

for

Search:↓

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Minoxidil and finasteride effectively treat hair loss.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.